复方苦参注射液的抗肿瘤作用研究进展  

Research advances in antitumor effect of Compound Matrine Injection

作　　者：王宇[1] 蒋梦影[2] 刘竞研[3] 朱枫[1] 

机构地区：[1]白求恩医科大学制药厂,长春130012 [2]吉林大学生命科学学院分子酶学工程教育部重点实验室,长春130012 [3]吉林大学药学院天然药物化学教研室,长春130021

出　　处：《国际生物制品学杂志》2015年第1期36-38,共3页International Journal of Biologicals

摘　　要：复方苦参注射液是由苦参和白土茯苓制成的抗肿瘤中药,属非特异性细胞毒药物,具有止血、止痛、抑制肿瘤细胞扩散等功能,同时还可以改善造血功能、增加机体免疫力,且无明显毒副作用.此文就复方苦参注射液在肿瘤治疗中的临床应用研究进展作一综述.Compound Matrine Injection made from Sophora flavescens and Rhizoma heterosmilacis is a non-specific cytotoxic antitumor drug in traditional Chinese medicine.It has a range of functions including hemostasis,analgesia,inhibiting tumor cell proliferation and so on.Compound Matrine Injection not only can improve the hematopoietic function and increase immunity but also has no evident side effect.This article reviews the research advances in clinical application of Compound Matrine Injection in tumor therapy.

关 键 词：中药 复方苦参注射液 肿瘤 治疗应用 

分 类 号：R286.0[医药卫生—中药学]